The global Newborn Screening for SMA and SCID market was valued at US$ 133 million in 2022 and is projected to reach US$ 276.3 million by 2029, at a CAGR of 11.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were …Read More>>
The global Artificial Joints market was valued at US$ 17710 million in 2022 and is projected to reach US$ 27720 million by 2029, at a CAGR of 6.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while…Read More>>
The global Newborn Screening Instruments market was valued at US$ 481.4 million in 2022 and is projected to reach US$ 770.9 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were cons…Read More>>
The global Evening Primrose Oil market was valued at US$ 216.2 million in 2022 and is projected to reach US$ 296 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered whil…Read More>>
The global Recombinant Proteins market was valued at US$ 1004 million in 2022 and is projected to reach US$ 2284.2 million by 2029, at a CAGR of 12.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered w…Read More>>
The global Cell Culture Media market was valued at US$ 2515.6 million in 2022 and is projected to reach US$ 4620.1 million by 2029, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered wh…Read More>>
The global Soft Gelatin Capsules (Softgels) market was valued at US$ 4356.6 million in 2022 and is projected to reach US$ 5703.6 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were…Read More>>
The global Recombinant Human Serum Albumin market was valued at US$ 77 million in 2022 and is projected to reach US$ 123.4 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were consi…Read More>>
The global Biologics and Biosimilars market was valued at US$ 481830 million in 2022 and is projected to reach US$ 843370 million by 2029, at a CAGR of 8.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were consid…Read More>>
The global Peptide CDMO market was valued at US$ 3265.7 million in 2022 and is projected to reach US$ 8327.1 million by 2029, at a CAGR of 14.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while e…Read More>>
